Does MILTEFOSINE Cause Therapy cessation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Therapy cessation have been filed in association with MILTEFOSINE (IMPAVIDO). This represents 3.7% of all adverse event reports for MILTEFOSINE.
9
Reports of Therapy cessation with MILTEFOSINE
3.7%
of all MILTEFOSINE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy cessation From MILTEFOSINE?
Of the 9 reports, 1 (11.1%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MILTEFOSINE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does MILTEFOSINE Cause?
Off label use (83)
Drug ineffective (58)
Drug ineffective for unapproved indication (44)
Nausea (42)
Disease recurrence (23)
Vomiting (19)
Condition aggravated (16)
Visceral leishmaniasis (15)
Decreased appetite (14)
Product use in unapproved indication (14)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which MILTEFOSINE Alternatives Have Lower Therapy cessation Risk?
MILTEFOSINE vs MINERAL OIL
MILTEFOSINE vs MINERAL OIL\PETROLATUM
MILTEFOSINE vs MINERALS
MILTEFOSINE vs MINERALS\VITAMINS
MILTEFOSINE vs MINIVELLE